NCT02366338

Brief Summary

Atrial fibrillation is the major cause of acute ischemic stroke. The risk of stroke was shown to decline by oral anticoagulant therapy. The investigators intended to evaluate appropriate use of anticoagulants in non-valvular AF patients.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
148

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2014

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2014

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 8, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 19, 2015

Completed
3 months until next milestone

Results Posted

Study results publicly available

May 21, 2015

Completed
Last Updated

May 21, 2015

Status Verified

April 1, 2015

Enrollment Period

3 months

First QC Date

February 8, 2015

Results QC Date

April 30, 2015

Last Update Submit

April 30, 2015

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Patients With at Least One Inappropriate MAI Criterion

    Appropriateness of oral anticoagulants was evaluated by adapted versions of the MAI

    1 day

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Non-valvular AF patients

You may qualify if:

  • Non valbular AF \>18 years

You may not qualify if:

  • Not currently receiving anticoagulant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Atrial Fibrillation

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Ozcan Basaran
Organization
Mugla Sitki Kocman University

Study Officials

  • Ozcan Basaran

    Muğla Sıtkı Koçman University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

February 8, 2015

First Posted

February 19, 2015

Study Start

August 1, 2014

Primary Completion

November 1, 2014

Study Completion

November 1, 2014

Last Updated

May 21, 2015

Results First Posted

May 21, 2015

Record last verified: 2015-04